FDA Extra FY 2003 Funding, User Fee Program Launch A Given – Industry
This article was originally published in The Gray Sheet
Executive Summary
FDA will receive the additional $15 mil. in funding that it needs in FY 2003 to implement the just-passed device user fee legislation, the medical device industry expects
You may also be interested in...
Hancock Jaffe Eyes Mid-Year Approval Of ProCol Vascular Bioprosthesis
Hancock Jaffe will begin this spring a 180-patient randomized trial of its ProCol prosthetic hemodialysis vascular graft as a replacement for failed native arteriovenous (AV) fistulae
Hancock Jaffe Eyes Mid-Year Approval Of ProCol Vascular Bioprosthesis
Hancock Jaffe will begin this spring a 180-patient randomized trial of its ProCol prosthetic hemodialysis vascular graft as a replacement for failed native arteriovenous (AV) fistulae
IVD National Fee Schedule, MDUFMA Oversight Among AdvaMed 2003 Goals
Securing adequate Medicare payment for in vitro diagnostics is one of several legislative priorities for AdvaMed in 2003